Clinical Trials / Medical Discoveries


PLEASANTON, California, December 16, 2011 - - The test confidently detects HLA-B*5701 to help decrease risk of abacavir hypersensitivity reaction Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its HLA-B*5701 screening test[1] is now commercially available in Europe.

LEUVEN, Belgium and LUND, Sweden, December 16, 2011 - ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce today that they have completed the enrolment of a 632-patient Phase IIb trial with their novel long-acting anticoagulant TB-402 (factor VIII inhibitor) for the prophylaxis of venous thromboembolism (VTE) after total hip surgery.

BOSTON, December 15, 2011 - Enlight Biosciences LLC announced today that it has formed new partnerships with AstraZeneca and Novo Nordisk.As partners in Enlight, AstraZeneca and Novo Nordisk will have the opportunity to collaborate and invest in the development of potentially transformational technologies with application to their therapeutic programs. Enlight was created by PureTech Ventures in partnership with major pharmaceutical companies and academic luminaries to proactively address critical unmet industry needs.

ZUTPHEN, The Netherlands, December 14, 2011 - It is part of Cryo-Save's educational program deployment to increase the awareness of stem cells therapy and regenerative medicine amongst healthcare professionals.
Older News
S M T W T F S
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
Copyright© 2011 The Gaea Times